Fornarini, Giuseppe

Phase II Study of Oxaliplatin and Gemcitabine Salvage Chemotherapy in Patients with Cisplatin-Refractory Nonseminomatous Germ Cell Tumor

De Giorgi, U., Rosti, G., Aieta, M., Testore, F., Burattini, L., Fornarini, G., Naglieri, E., Lo Re, G., Zumaglini, F., & Marangolo, M. (2006) · European Urology

Testicular diseases and treatmentsOvarian cancer diagnosis and treatment

Cited by 81

Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis

Messina, C., Giunta, E. F., Signori, A., Rebuzzi, S. E., Banna, G. L., Maniam, A., Buti, S., Cattrini, C., Fornarini, G., Bauckneht, M., et al. (2024) · European Urology Oncology

Prostate Cancer Treatment and ResearchPARP inhibition in cancer therapy

Cited by 39

LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial

Ciccarese, C., Porcari, S., Buti, S., Fornarini, G., Primi, F., Giudice, G. C., Damassi, A., Giron Berrios, J. R., Stumbo, L., Arduini, D., et al. (2024) · Annals of Oncology

Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers

Cited by 35